ARTICLE
10 June 2020

Jones Day Presents: The Impact Of Digital Health On Research And Clinical Trials (Video)

JD
Jones Day

Contributor

Jones Day is a global law firm with more than 2,500 lawyers across five continents. The Firm is distinguished by a singular tradition of client service; the mutual commitment to, and the seamless collaboration of, a true partnership; formidable legal talent across multiple disciplines and jurisdictions; and shared professional values that focus on client needs.
Digital health technologies have brought a number of significant breakthroughs to clinical trial programs, including faster patient recruitment, more efficient data collection, and better tracking...
United States Food, Drugs, Healthcare, Life Sciences

Digital health technologies have brought a number of significant breakthroughs to clinical trial programs, including faster patient recruitment, more efficient data collection, and better tracking of biometric information. But the new technologies also introduce several complicated legal issues. Jones Day partners Maureen Bennett and Cristiana Spontoni talk about privacy concerns, security measures, changes to the informed consent process, data integrity, and the integration of third-party technologies to regulatory protocols.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More